Chronic automated red cell exchange therapy for sickle cell disease

Area of Science:

• Hematology
• Transfusion Medicine
• Sickle Cell Disease Management

Background:

• Limited data exists on chronic automated red cell exchange (RCE) for sickle cell disease (SCD) beyond stroke prevention, particularly in adult populations.
• Understanding the indications and outcomes of RCE in adults with SCD is crucial for optimizing treatment strategies.

Purpose of the Study:

• To evaluate the utilization, indications, and outcomes of chronic automated red cell exchange (RCE) in adult patients with sickle cell disease (SCD).
• To assess adverse events associated with chronic RCE and its impact on acute care utilization.

Main Methods:

• Retrospective analysis of 164 adult patients with SCD undergoing chronic RCE over a 10-year period.
• Evaluation of patient demographics, referral indications, procedural details, and adverse events.
• Subanalysis comparing acute care encounters before and after RCE initiation.

Main Results:

• Refractory pain (44.5%) and iron overload (34.7%) were the primary referral indications for chronic RCE.
• Central vascular access complications included thrombosis (6%) and infection (12%).
• New red blood cell (RBC) antibodies developed in 11.4% of previously non-alloimmunized patients; no significant reduction in acute care encounters was observed in adherent patients.

Conclusions:

• Chronic RCE in adult SCD patients is utilized for indications like refractory pain and iron overload.
• Potential risks include central line-associated complications and RBC alloimmunization.
• Further prospective studies are required to identify patient subgroups most likely to benefit from chronic RCE.